Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Endologix, Inc.

TRADE

NASDAQ: ELGXHealthcare / Medical Instruments & Supplies / USA
1.74-0.02-1.14%Vol 248 1181Y Perf -65.10%
Oct 17th, 2018 16:00
BID1.74 ASK1.75
Open1.74 Previous Close1.76
Pre-Market- After-Trading1.74
 - -%  - -%
Target Price
3.83 
Analyst Rating
Hold 3.25
Potencial %
120.12 
Finscreener Ranking
+     38.21
Insiders Trans % 3/6/12M
100/-/- 
Value Ranking
+     32.74
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
+     30.83
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)147 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
4.78 
Earnings Date
6th Nov 2018

Today's Price Range

1.661.76

 

52wk Range

1.496.72

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
1.16%
3 Months
-67.42%
6 Months
-59.63%
1 Year
-65.10%
3 Years
-87.48%
5 Years
-89.75%

Quotes

Name / TickerPriceChg.Chg.%
ELGX1.74-0.0200-1.14
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.10
Current Ratio 1.90
Long Term Debt to Total Capital 0.84
Total Debt to Equity 5.82
Interest Coverage -2.10
Leverage Ratio 7.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin66.90
EBIT Margin-27.90
EBITDA Margin-23.20
Pre-tax Profit Margin-38.00
Profit Margin-44.65
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.52
PS Ratios 1.06
Price to Cash Flow 506.70
Price to Free Cash Flow -5.50
Cash Flow Per Share -0.43
Price to Tangible Book-0.87
Book Value per Share0.47
Enterprise Value (in ths.)334 601
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-64.09
ROE last 12 Months -104.55
Return on Assets (5Y Avg) -18.02
ROA last 12 Months -19.45
Return on Capital (5Y Avg) -21.40
ROC last 12 Months -15.96
Return on invested Capital Q -6.47
Return on invested Capital Y-14.62
Assets Turnover0.30
Receivables Turnover3.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)131 027
Revenue per Share 1.55
Revenue Growth 3 Years 0.14
Revenue Growth 5 Years 5.15
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.19-0.185.26
Q01 2018-0.20-0.1620.00
Q04 2017-0.22-0.0863.64
Q03 2017-0.17-0.1135.29
Q02 2017-0.19-0.1047.37
Q01 2017-0.24-0.1825.00
Q04 2016-0.18-0.22-22.22
Q03 2016-0.14-0.1121.43
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.25-38.89Negative
12/2018 QR-0.23-27.78Negative
12/2018 FY-0.86-22.86Negative
12/2019 FY-0.69-16.95Negative
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.25
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume248 118
Shares Outstanding (in ths.)84 710
Trades Count851
Dollar Volume397 305
Avg. Volume659 188
Avg. Weekly Volume478 226
Avg. Monthly Volume781 317
Avg. Quarterly Volume810 882

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

75%25%

Bearish Bullish

63%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (14.29 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (87.50 %)
7 (87.50 %)
5 (71.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (12.50 %)
1 (12.50 %)
1 (14.29 %)
RatingHold
3.25
Hold
3.25
Hold
3.00

There are no comments yet.

News

x